Merit Net Income from 2010 to 2026

MMSI Stock  USD 77.18  0.84  1.08%   
Merit Medical's Net Income is increasing with slightly volatile movements from year to year. Net Income is estimated to finish at about 134.9 M this year. For the period between 2010 and 2026, Merit Medical, Net Income quarterly trend regression had mean deviation of  37,832,048 and range of 144.8 M. View All Fundamentals
 
Net Income  
First Reported
1989-03-31
Previous Quarter
27.8 M
Current Value
38 M
Quarterly Volatility
8.7 M
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Merit Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Merit Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 141.4 M, Interest Expense of 27.8 M or Total Revenue of 1.6 B, as well as many indicators such as Price To Sales Ratio of 2.74, Dividend Yield of 0.0 or PTB Ratio of 3.62. Merit financial statements analysis is a perfect complement when working with Merit Medical Valuation or Volatility modules.
  
Build AI portfolio with Merit Stock
Check out the analysis of Merit Medical Correlation against competitors.
The Net Income trend for Merit Medical Systems offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Merit Medical is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.

Latest Merit Medical's Net Income Growth Pattern

Below is the plot of the Net Income of Merit Medical Systems over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Merit Medical Systems financial statement analysis. It represents the amount of money remaining after all of Merit Medical Systems operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Merit Medical's Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Merit Medical's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 128.49 M10 Years Trend
Slightly volatile
   Net Income   
       Timeline  

Merit Net Income Regression Statistics

Arithmetic Mean46,594,674
Geometric Mean26,391,343
Coefficient Of Variation99.58
Mean Deviation37,832,048
Median23,802,000
Standard Deviation46,398,829
Sample Variance2152.9T
Range144.8M
R-Value0.80
Mean Square Error814.2T
R-Squared0.65
Significance0.0001
Slope7,381,945
Total Sum of Squares34445.6T

Merit Net Income History

2026134.9 M
2025128.5 M
2024120.4 M
202394.4 M
202274.5 M
202148.5 M
2020-9.8 M

Other Fundumenentals of Merit Medical Systems

Merit Medical Net Income component correlations

About Merit Medical Financial Statements

Investors use fundamental indicators, such as Merit Medical's Net Income, to determine how well the company is positioned to perform in the future. Although Merit Medical's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Net Income128.5 M134.9 M
Net Income Applicable To Common Shares85.7 M90 M
Net Income From Continuing Ops138.4 M145.3 M
Net Income Per Share 2.17  2.28 
Net Income Per E B T 0.75  0.62 

Currently Active Assets on Macroaxis

When determining whether Merit Medical Systems offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Merit Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Merit Medical Systems Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Merit Medical Systems Stock:
Check out the analysis of Merit Medical Correlation against competitors.
You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Is there potential for Health Care Equipment & Supplies market expansion? Will Merit introduce new products? Factors like these will boost the valuation of Merit Medical. Expected growth trajectory for Merit significantly influences the price investors are willing to assign. Understanding fair value requires weighing current performance against future potential. All the valuation information about Merit Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.388
Earnings Share
1.95
Revenue Per Share
25.625
Quarterly Revenue Growth
0.109
Return On Assets
0.0475
Investors evaluate Merit Medical Systems using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Merit Medical's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. External factors like market trends, sector rotation, and investor psychology can cause Merit Medical's market price to deviate significantly from intrinsic value.
Understanding that Merit Medical's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Merit Medical represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Merit Medical's market price signifies the transaction level at which participants voluntarily complete trades.